GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fusion Pharm Inc (OTCPK:FSPM) » Definitions » EV-to-EBITDA

Fusion Pharm (Fusion Pharm) EV-to-EBITDA : (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Fusion Pharm EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fusion Pharm's enterprise value is $0.00 Mil. Fusion Pharm does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Fusion Pharm's EV-to-EBITDA at this moment.

The historical rank and industry rank for Fusion Pharm's EV-to-EBITDA or its related term are showing as below:

FSPM's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.715
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Fusion Pharm's stock price is $0.0001. Fusion Pharm does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Fusion Pharm's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Fusion Pharm EV-to-EBITDA Historical Data

The historical data trend for Fusion Pharm's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Pharm EV-to-EBITDA Chart

Fusion Pharm Annual Data
Trend
EV-to-EBITDA

Fusion Pharm Quarterly Data
EV-to-EBITDA

Competitive Comparison of Fusion Pharm's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Fusion Pharm's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fusion Pharm's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fusion Pharm's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fusion Pharm's EV-to-EBITDA falls into.



Fusion Pharm EV-to-EBITDA Calculation

Fusion Pharm's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=


Fusion Pharm  (OTCPK:FSPM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Fusion Pharm's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Fusion Pharm EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fusion Pharm's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Fusion Pharm (Fusion Pharm) Business Description

Traded in Other Exchanges
N/A
Address
5850 East 58th Avenue, Unit F, Commerce City, CO, USA, 80022
Fusion Pharm Inc is engaged in commercializing its patent pending PharmPods line of hydroponic cultivation systems. Its PharmPods are used for agricultural cultivation by urban farming companies and other specialty growers. Pharmpods are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation.

Fusion Pharm (Fusion Pharm) Headlines

No Headlines